Renewed Psychedelic Interest

Albert discusses the resurgence of interest in psychedelics, attributing it to a generational shift away from traditional psychiatric medications and a desire for alternative treatments. He highlights significant socioeconomic and racial disparities in research participation, raising concerns about the accessibility of potential psychedelic therapies. The conversation underscores the importance of insurance coverage in determining whether these treatments can be widely available.